Viavi Solutions Inc. has evolved from a telecom-centric company to a diversified growth firm, with AI data centers and aerospace/defense now generating two-thirds of its Network and Service Enablement (NSE) revenue. The company reported a 40% revenue increase to $1.52 billion in fiscal 2026 and expanded its non-GAAP operating margin to 20.6%. Q4 revenue surged 52.5% year-over-year, reflecting strong operational momentum. Growth was supported by acquisitions of Spirent and Inertial Labs, and a $575 million equity raise strengthened the balance sheet but caused shareholder dilution. Despite robust growth, Viavi's stock trades at 20.6 times fiscal 2027 earnings, indicating limited upside and justifying a Hold rating as expectations have already been raised.
Viavi Solutions is the subject of this market context update. For readers following the Technology sector, here is Pluang's market snapshot as of Sep 15, 2026 21:21 WIB: of 150 priced Technology-sector US stocks tradable on Pluang, 50 rose and 96 fell today. Notable price changes include RIG at USD 5.65 (+3.67%), NOK at USD 9.99 (+3.52%), and HPE at USD 57.32 (+3.45%).
Waystar Holding Corp, a healthcare software company valued at around $5.1 billion, saw its stock rise 8.6% to $27.05 following reports that it is evaluating strategic options, including a potential sale. Barclays set a new price target of $30, sugges...
MasterCraft Boat Holdings reported fiscal Q4 2026 adjusted earnings of $0.67 per share and revenue of $129.94 million, surpassing estimates. Revenue growth was driven by its Performance and Wake business and the Marine Products acquisition, which add...
Redwood Trust's CFO, Carillo Brooke, increased her stake by purchasing 26,065 shares, showing confidence despite a major shareholder urging the board to consider selling the company. The stock trades at a 33% discount to its GAAP book value due to ri...
BioMarin Pharmaceutical received a price target upgrade to $97 from BMO Capital, reflecting about 50% upside from current levels. This follows positive Phase 3 trial results for VOXZOGO®, a treatment for hypochondroplasia, showing significant growth ...
Comcast announced a strategic restructuring to separate its connectivity and technology division from its media operations, including NBCUniversal and Sky. UBS raised Comcast's price target to $27, suggesting a 10% upside from current prices. The com...
